Special Issue "Immunomodulatory Vaccines against Autoimmune Diseases"

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: closed (15 October 2022) | Viewed by 90

Special Issue Editor

Director of Multiple Sclerosis & Demyelinating Diseases Unit and Immunogenetics Laboratory, 1st Department of Neurology of Medical School, National and Kapodistrian University of Athens, Aeginition University Hospital, Vas. Sofias Ave 74, 115 28 Athens, Greece
Interests: clinical immunology; immunogenetics; neurology; multiple sclerosis; demyelinating diseases; autoimmunity
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Vaccination makes a huge contribution to preventing many infectious diseases and reducing the associated morbidity and mortality. It is a key pillar of an effective health care system. However, there is not much research on vaccination and autoimmune diseases. On the other hand, autoimmune diseases are often treated with immunotherapy. Whether vaccines are equally effective for each treatment requires further clarification.

This Special Issue will focus on recent advances in autoimmune diseases and immunomodulatory vaccines. Based on your extensive knowledge and experience in the field, we cordially invite you to participate in this Special Issue.

Dr. Maria Anagnostouli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • autoimmune Diseases
  • clinical immunology
  • vaccination
  • immunomodulatory vaccines

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop